P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENSTRÖM’S MACROGLOBULINEMIA
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000847288.62394.e8 |
| _version_ | 1797287223842832384 |
|---|---|
| author | M.-A. Dimopoulos K. Amaador M. C. Minnema K. Nasserinejad M. Kap E. Kastritis M. Gavriatopoulou W. Kraan M. E. D. Chamuleau D. Deeren L. Tick J. K. Doorduijn F. Offner L. H. Böhmer R. D. Liu S. T. Pals J. M. Vos M. J. Kersten |
| author_facet | M.-A. Dimopoulos K. Amaador M. C. Minnema K. Nasserinejad M. Kap E. Kastritis M. Gavriatopoulou W. Kraan M. E. D. Chamuleau D. Deeren L. Tick J. K. Doorduijn F. Offner L. H. Böhmer R. D. Liu S. T. Pals J. M. Vos M. J. Kersten |
| author_sort | M.-A. Dimopoulos |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:29:51Z |
| format | Article |
| id | doaj.art-488674220b9c4f3a9c3f8b48bc9586d4 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:29:51Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-488674220b9c4f3a9c3f8b48bc9586d42024-03-02T06:40:32ZengWileyHemaSphere2572-92412022-06-01699599610.1097/01.HS9.0000847288.62394.e8202206003-00995P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENSTRÖM’S MACROGLOBULINEMIAM.-A. Dimopoulos0K. Amaador1M. C. Minnema2K. Nasserinejad3M. Kap4E. Kastritis5M. Gavriatopoulou6W. Kraan7M. E. D. Chamuleau8D. Deeren9L. Tick10J. K. Doorduijn11F. Offner12L. H. Böhmer13R. D. Liu14S. T. Pals15J. M. Vos16M. J. Kersten171 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece2 Department Of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam4 Department of Hematology, University Medical Center Utrecht, University Utrecht, Utrecht5 HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam5 HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece3 LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam7 Department of Hematology, Amsterdam UMC, VU University, Amsterdam, Netherlands8 Department of Hematology, AZ Delta, Roeselare, Belgium9 Department of Hematology, Maxima Medical Center, Eindhoven10 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands11 Department of Hematology, University Hospital Gent, Gent, Belgium12 Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands2 Department Of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam3 LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam2 Department Of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam2 Department Of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdamhttp://journals.lww.com/10.1097/01.HS9.0000847288.62394.e8 |
| spellingShingle | M.-A. Dimopoulos K. Amaador M. C. Minnema K. Nasserinejad M. Kap E. Kastritis M. Gavriatopoulou W. Kraan M. E. D. Chamuleau D. Deeren L. Tick J. K. Doorduijn F. Offner L. H. Böhmer R. D. Liu S. T. Pals J. M. Vos M. J. Kersten P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENSTRÖM’S MACROGLOBULINEMIA HemaSphere |
| title | P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENSTRÖM’S MACROGLOBULINEMIA |
| title_full | P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENSTRÖM’S MACROGLOBULINEMIA |
| title_fullStr | P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENSTRÖM’S MACROGLOBULINEMIA |
| title_full_unstemmed | P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENSTRÖM’S MACROGLOBULINEMIA |
| title_short | P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENSTRÖM’S MACROGLOBULINEMIA |
| title_sort | p1105 final results of the phase i ii hovon124 ecwm r2 study including 2 year rituximab maintenance after induction with ixazomib rituximab and dexamethasone in relapsed waldenstrom s macroglobulinemia |
| url | http://journals.lww.com/10.1097/01.HS9.0000847288.62394.e8 |
| work_keys_str_mv | AT madimopoulos p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT kamaador p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT mcminnema p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT knasserinejad p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT mkap p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT ekastritis p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT mgavriatopoulou p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT wkraan p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT medchamuleau p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT ddeeren p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT ltick p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT jkdoorduijn p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT foffner p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT lhbohmer p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT rdliu p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT stpals p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT jmvos p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia AT mjkersten p1105finalresultsofthephaseiiihovon124ecwmr2studyincluding2yearrituximabmaintenanceafterinductionwithixazomibrituximabanddexamethasoneinrelapsedwaldenstromsmacroglobulinemia |